Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ACM Appoints European BD Head | Contract Pharma
Breaking News, Promotions & Moves

ACM Appoints European BD Head

Struik responsible for business development efforts throughout the region

Isabel Struik has been appointed head of business development in Europe for ACM Global Central Lab. Ms. Struik joins the executive management team and will be responsible for business development efforts throughout the region. She has extensive experience in clinical research having worked in the industry for more than 13 years, in all major therapeutic areas.

Prior to joining the company, she was director of business development at Cromsource, an international provider of clinical development services, where she was head of business development. Prior to that, she was associate director, business development for PharmaNet, where she was responsible for establishing a generics and biosimilars product portfolio for late stage studies. Ms. Struik also spent several years at Kendle International, where she served in roles of increasing strategic responsibility, including business development and support manager.

“Isabel has extensive business development experience in the clinical trials industry and a thorough understanding of the logistics and challenges involved when it comes to central lab activities in clinical research,” said Angela J. Panzarella, president of ACM Global Central Lab. “We are thrilled to welcome her to our team.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters